Paper20523901
Few and far between: how HIV may be evading antibody avidity.
Klein JS and 1 other. PLoS Pathog, 2010. Cited by 239 papers, by iCite.
Cite this record
ConductScience Library. Few and far between: how HIV may be evading antibody avidity. Papers, record 20523901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20523901
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Antibodies | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| AIDS Vaccines | |
| Antibody Affinity | |
| Antibody Specificity | |
| Humans | |
| Mutation | |
| Protein Structure, Quaternary |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Howard Hughes Medical Institute | United States | PubMed |
Source PubMed
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18313941 | Zernike phase contrast electron microscopy of ice-embedded influenza A virus. | J Struct Biol | 2008 | https://conductscience.org/library/papers/18313941 | PubMed |
| 2 | 16862157 | Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody. | Nat Struct Mol Biol | 2006 | https://conductscience.org/library/papers/16862157 | PubMed |
| 3 | 19287373 | Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. | Nature | 2009 | https://conductscience.org/library/papers/19287373 | PubMed |
| 4 | 16160141 | Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1. | J Virol | 2005 | https://conductscience.org/library/papers/16160141 | PubMed |
| 5 | 15308718 | Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. | J Virol | 2004 | https://conductscience.org/library/papers/15308718 | PubMed |
| 6 | 8627711 | Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. | J Virol | 1996 | https://conductscience.org/library/papers/8627711 | PubMed |
| 7 | 17901336 | Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. | Science | 2007 | https://conductscience.org/library/papers/17901336 | PubMed |
| 8 | 1386485 | Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. | Virology | 1992 | https://conductscience.org/library/papers/1386485 | PubMed |
| 9 | 12634368 | Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12. | J Virol | 2003 | https://conductscience.org/library/papers/12634368 | PubMed |
| 10 | 19843556 | HIV vaccine trial results--an opening for further research. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19843556 | PubMed |
| 11 | 18945777 | Design and expression of a dimeric form of human immunodeficiency virus type 1 antibody 2G12 with increased neutralization potency. | J Virol | 2009 | https://conductscience.org/library/papers/18945777 | PubMed |
| 12 | 9371638 | Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein. | J Virol | 1997 | https://conductscience.org/library/papers/9371638 | PubMed |
| 13 | 11991960 | Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. | J Virol | 2002 | https://conductscience.org/library/papers/11991960 | PubMed |
| 14 | 17928656 | A dynamical study of antibody-antigen encounter reactions. | Phys Biol | 2007 | https://conductscience.org/library/papers/17928656 | PubMed |
| 15 | 18842730 | Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. | J Virol | 2008 | https://conductscience.org/library/papers/18842730 | PubMed |
| 16 | 11581389 | Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event. | J Virol | 2001 | https://conductscience.org/library/papers/11581389 | PubMed |
| 17 | 17480119 | Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry. | PLoS Pathog | 2007 | https://conductscience.org/library/papers/17480119 | PubMed |
| 18 | 15627210 | Binding parameters of antibodies: pseudo-affinity and other misconceptions. | Cancer Immunol Immunother | 2005 | https://conductscience.org/library/papers/15627210 | PubMed |
| 19 | 12970440 | Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. | J Virol | 2003 | https://conductscience.org/library/papers/12970440 | PubMed |
| 20 | 20357769 | Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity. | Nat Struct Mol Biol | 2010 | https://conductscience.org/library/papers/20357769 | PubMed |
Cited by193
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 239 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42806979 | Antigenic remodeling of the SARS-CoV-2 Spike N-terminal domain links sequence variability to structural reorganization of a neutralizing antibody supersite. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42806979 | PubMed |
| 42749798 | Mutational constraints on RSV F and its neutralization by antibodies. | Nature | 2026 | https://conductscience.org/library/papers/42749798 | PubMed |
| 42330958 | Analysis of West Nile disease convalescents identifies human monoclonal antibodies protective against West Nile and related orthoflaviviruses. | Immunity | 2026 | https://conductscience.org/library/papers/42330958 | PubMed |
| 42069746 | High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/42069746 | PubMed |
| 42012184 | Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. | J Virol | 2026 | https://conductscience.org/library/papers/42012184 | PubMed |
| 41993435 | Human antibodies against West Nile and related orthoflaviviruses. | bioRxiv | 2026 | https://conductscience.org/library/papers/41993435 | PubMed |
| 41965897 | Cryo-ET of IgG bivalent binding on SARS-CoV-2 provides structural basis for antibody avidity. | Nat Commun | 2026 | https://conductscience.org/library/papers/41965897 | PubMed |
| 41648420 | Reconstructing a Missing Link of HIV-1 Assembly: HIV-1 Envelope-Matrix Interactions in a Native Viral Context. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648420 | PubMed |
| 41642934 | Antigen flexibility supports the avidity of hemagglutinin-specific antibodies at low antigen densities. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41642934 | PubMed |
| 41634487 | Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitope. | Nat Immunol | 2026 | https://conductscience.org/library/papers/41634487 | PubMed |
| 41583464 | Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection. | Front Immunol | 2025 | https://conductscience.org/library/papers/41583464 | PubMed |
| 41373539 | Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373539 | PubMed |
| 40964353 | Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitope. | bioRxiv | 2025 | https://conductscience.org/library/papers/40964353 | PubMed |
| 40955274 | Chimeric antigen receptor T-cell therapy and bispecific antibodies in the treatment of lymphoma for human immunodeficiency virus-infected patients: A systematic review. | SAGE Open Med | 2025 | https://conductscience.org/library/papers/40955274 | PubMed |
| 40904452 | Molecular ingredients of an immunogen for long-lasting IgG. | Front Immunol | 2025 | https://conductscience.org/library/papers/40904452 | PubMed |
| 40628289 | Understanding antibody-target antigen interactions and the avidity effect using mathematical modelling. | J R Soc Interface | 2025 | https://conductscience.org/library/papers/40628289 | PubMed |
| 40338637 | Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein. | Elife | 2025 | https://conductscience.org/library/papers/40338637 | PubMed |
| 40285021 | Superior Potency of Synthetic Virus-like Structures in Vaccine-Induced Antibody Responses Compared to Qβ Bacteriophage Virus-like Particles. | Viruses | 2025 | https://conductscience.org/library/papers/40285021 | PubMed |
| 40193609 | Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40193609 | PubMed |
| 39746910 | The molecular reach of antibodies crucially underpins their viral neutralisation capacity. | Nat Commun | 2025 | https://conductscience.org/library/papers/39746910 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 | NCBI Gene |
| FANCB | 2187 | PubTator's text mining | https://conductscience.org/library/genes/2187 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
| NDUFB3 | 4709 | PubTator's text mining | https://conductscience.org/library/genes/4709 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20523901
GET https://conductscience.org/api/papers/v1/20523901/references?page=2